[go: up one dir, main page]

TR201009395A2 - Effervescent formulations with improved taste. - Google Patents

Effervescent formulations with improved taste.

Info

Publication number
TR201009395A2
TR201009395A2 TR2010/09395A TR201009395A TR201009395A2 TR 201009395 A2 TR201009395 A2 TR 201009395A2 TR 2010/09395 A TR2010/09395 A TR 2010/09395A TR 201009395 A TR201009395 A TR 201009395A TR 201009395 A2 TR201009395 A2 TR 201009395A2
Authority
TR
Turkey
Prior art keywords
improved taste
effervescent formulations
effervescent
formulations
taste
Prior art date
Application number
TR2010/09395A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09395A priority Critical patent/TR201009395A2/en
Publication of TR201009395A2 publication Critical patent/TR201009395A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş aktif ajan olarak rosuvastatin ve/veya farmasötik olarak kabul edilebilir bir tuzunu içeren ve tadı iyileştirilmiş efervesan formulasyonlara, bunların hazırlanışına ve kullanımına yöneliktir.The present invention is directed to effervescent formulations which have improved taste, including rosuvastatin and / or a pharmaceutically acceptable salt thereof, as an active agent, their preparation and use.

TR2010/09395A 2010-11-11 2010-11-11 Effervescent formulations with improved taste. TR201009395A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2010/09395A TR201009395A2 (en) 2010-11-11 2010-11-11 Effervescent formulations with improved taste.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09395A TR201009395A2 (en) 2010-11-11 2010-11-11 Effervescent formulations with improved taste.

Publications (1)

Publication Number Publication Date
TR201009395A2 true TR201009395A2 (en) 2012-05-21

Family

ID=47003421

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09395A TR201009395A2 (en) 2010-11-11 2010-11-11 Effervescent formulations with improved taste.

Country Status (1)

Country Link
TR (1) TR201009395A2 (en)

Similar Documents

Publication Publication Date Title
LT3175711T (en) PARASITICIDAL COMPOSITIONS INCLUDING MULTIPLE ACTIVE AGENTS, METHODS OF THEIR PREPARATION AND USE
MX2013002597A (en) Pesticidal arylpyrrolidines.
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201300989A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF TAPENTADOL FOR Oral administration
BR112014019171A8 (en) DEXDETOMIDE INTRANASAL COMPOSITIONS AND THEIR METHODS OF USE
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
MX348823B (en) Stable formulations of linaclotide.
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
TW200942530A (en) Pyridine compounds
UA115357C2 (en) Pyridin-4-yl derivatives
TR201009394A2 (en) Improved montelukast formulations.
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2012065028A3 (en) Substituted tetracyclines
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
TR201007926A1 (en) Prasugrel tablet formulations.
TR201009395A2 (en) Effervescent formulations with improved taste.
WO2013072770A3 (en) Pharmaceutical formulations comprising atorvastatin and glimepiride
TR201309037A2 (en) Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor
TR201100152A2 (en) Effervescent compositions containing amlodipine.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TR201203083A2 (en) Pharmaceutical dosage form comprising cefdinir and clavulanic acid.
TR201203085A2 (en) Compositions containing sefetamet and clavulanic acid.